You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 143 No. 11, November 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •CME Course for This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Colon Cancer
 •Colorectal Surgery
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

A Randomized Controlled Trial to Improve Lymph Node Assessment in Stage II Colon Cancer

Frances C. Wright, MD; Anna R. Gagliardi, PhD; Calvin H. L. Law, MD; Linda D. Last, CCRP; A. Eric Klevan, MD; Sermsak Hongjinda, MD; Larry W. Stitt, MSc; Neil Klar, PhD; David P. Ryan, PhD; Andrew J. Smith, MD

Arch Surg. 2008;143(11):1050-1055.

Hypothesis  Physicians seem to learn best from their peers, yet the impact of opinion leaders on physician behavior is unclear. Because colon cancer staging has been identified as being suboptimal in Ontario, Canada, we sought to evaluate the influence of expert and local opinion leaders for colon cancer on optimizing colon cancer lymph node assessment.

Design, Setting, Participants  A cluster-randomized trial including all hospitals in Ontario that identified a local opinion leader with intervention between January 5 and June 17, 2004.

Intervention  All 42 centers received a standardized lecture about colon cancer lymph node assessment delivered by an expert opinion leader in colon cancer. The 21 intervention hospitals also received academic detailing of a local opinion leader by the expert opinion leader and a toolkit.

Main Outcome Measures  Mean number of lymph nodes assessed in patients with stage II colon cancer and the proportion of cases staged with a minimum of 12 lymph nodes before and after a standardized lecture were assessed.

Results  Patient demographic and tumor factors were similar in both groups before and after the standardized lecture. Lymph node assessment significantly improved after the standardized lecture at intervention and control sites (P < .001). No additional benefit of academic detailing and toolkit provision in the intervention was demonstrated.

Conclusions  In-person provision of information by an expert opinion leader in colon cancer may stimulate performance regarding lymph node assessment for colon cancer. Academic detailing of a local opinion leader did not further improve lymph node assessment.

Trial Registration  isrctn.org Identifier: ISRCTN56824239


Author Affiliations: Sunnybrook Health Sciences Centre, University of Toronto, Toronto (Drs Wright, Gagliardi, Law, Hongjinda, Ryan, and Smith and Ms Last); Division of General Surgery, McMaster University, West, Hamilton (Dr Klevan); and Department of Epidemiology and Biostatistics, University of Western Ontario, London (Mr Stitt and Dr Klar), Ontario, Canada.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

A Randomized Controlled Trial to Improve Lymph Node Assessment in Stage II Colon Cancer—Invited Critique
Clifford Y. Ko and Sushma Jain
Arch Surg. 2008;143(11):1055-1056.
EXTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.